Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
15.01.25
/
50%
€9.00
Target price
15.01.26
€20.29
Performance (%)
-41.11%
Price
24.07.25
€5.35
Summary
This prediction is currently active. Massive losses of -41.11% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 15.01.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | -8.696% | -8.696% |
| iShares Core DAX® | -0.519% | 2.329% |
| iShares Nasdaq 100 | -0.737% | 3.399% |
| iShares Nikkei 225® | 3.828% | 4.007% |
| iShares S&P 500 | -0.355% | 3.261% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
07.11.24
07.11.24
€19.47
07.11.25
07.11.25
-48.50%
24.07.25
24.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.00
20.09.24
20.09.24
€17.90
20.09.25
20.09.25
-47.00%
24.07.25
24.07.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
29.02.24
29.02.24
€20.36
28.02.25
28.02.25
-24.15%
01.03.25
01.03.25